Hemagglutination and Hemagglutination-Inhibition with Coxsackie B Viruses
Copyright policy )Hemagglutination and Hemagglutination-Inhibition with Coxsackie B Viruses
SummaryAgglutination of human erythrocytes by Coxsackie B virus types 1 and 5 is reported. Optimum titers were obtained with a sedimentation temperature of 37†C and the erythrocytes of newborn infants. A hemagglutination–inhibition (HI) procedure employing Coxsackie B virus types 1, 3, and 5 was used to test paired sera from 25 children infected with Coxsackie B virus types 3. 4. and 5. A significant homologous response was detected in every case except one. A few heterologous responses occurred in children with pre–existing HI antibody to one or more of the 3 test antigens.
- National Institutes of Health United States
- National Institute of Allergy and Infectious Diseases United States
Hemagglutination, Hemagglutination Tests, Hemagglutination Inhibition Tests, Enterovirus, Enterovirus B, Human
Hemagglutination, Hemagglutination Tests, Hemagglutination Inhibition Tests, Enterovirus, Enterovirus B, Human
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).30 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!